Aspirin for primary prevention of ST segment elevation myocardial infarction in persons with diabetes and multiple risk factors

BACKGROUND: Controversy exists as to whether low-dose aspirin use may give benefit in primary prevention of cardiovascular (CV) events. We hypothesized that the benefits of aspirin are underevaluated. METHODS: We investigated 12,123 Caucasian patients presenting to hospital with acute coronary syndr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:EClinicalMedicine
Main Authors: Bugiardini, Raffaele, Pavasović, Saša, Yoon, Jinsung, van der Schaar, Mihaela, Kedev, Sasko, Vavlukis, Marija, Vasiljevic, Zorana, Bergami, Maria, Miličić, Davor, Manfrini, Olivia, Cenko, Edina, Badimon, Lina
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2020
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7599315/
https://ncbi.nlm.nih.gov/pubmed/33150322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2020.100548
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares